Search research articles
Contact Us
Filters
Showing results (121-130 of 140) with videos related to
Page
of 14
Sort By:
Diabetes Care
|
September 10, 1999
Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects
S R Mudaliar, F A Lindberg, M Joyce, et al.
Diabetes, Obesity & Metabolism
|
May 15, 2015
Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes
S E Inzucchi, M A Nauck, U Hehnke, et al.
Clinical Therapeutics
|
April 25, 2001
Pharmacodynamic and pharmacokinetic properties of a premixed 85/15 human insulin preparation
S R Mudaliar, P Mohideen, S C Baxi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1993
Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity
K I Suh, C Murata, Y M Song, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1996
Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction
B Gumbiner, E Van Cauter, W F Beltz, et al.
The New England Journal of Medicine
|
February 19, 1987
The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus
H S Glauber, R R Henry, P Wallace, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
September 27, 2001
Effect of pravastatin-to-simvastatin conversion on low-density-lipoprotein cholesterol
M K Ito, J C Lin, A P Morreale, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1985
Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus
J M Olefsky, R R Revers, M Prince, et al.
Diabetes, Obesity & Metabolism
|
March 3, 2015
Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials
R R Henry, J B Buse, H Wu, et al.
International Journal of Clinical Practice
|
August 7, 2008
Is adiposopathy (sick fat) an endocrine disease?
H E Bays, J M González-Campoy, R R Henry, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 140) with videos related to
Sort By:
Page
of 14
Diabetes Care
|
September 10, 1999
Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects
S R Mudaliar, F A Lindberg, M Joyce, et al.
Diabetes, Obesity & Metabolism
|
May 15, 2015
Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes
S E Inzucchi, M A Nauck, U Hehnke, et al.
Clinical Therapeutics
|
April 25, 2001
Pharmacodynamic and pharmacokinetic properties of a premixed 85/15 human insulin preparation
S R Mudaliar, P Mohideen, S C Baxi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1993
Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity
K I Suh, C Murata, Y M Song, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1996
Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction
B Gumbiner, E Van Cauter, W F Beltz, et al.
The New England Journal of Medicine
|
February 19, 1987
The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus
H S Glauber, R R Henry, P Wallace, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
September 27, 2001
Effect of pravastatin-to-simvastatin conversion on low-density-lipoprotein cholesterol
M K Ito, J C Lin, A P Morreale, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1985
Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus
J M Olefsky, R R Revers, M Prince, et al.
Diabetes, Obesity & Metabolism
|
March 3, 2015
Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials
R R Henry, J B Buse, H Wu, et al.
International Journal of Clinical Practice
|
August 7, 2008
Is adiposopathy (sick fat) an endocrine disease?
H E Bays, J M González-Campoy, R R Henry, et al.
Page
of 14